STAT+: Pharmalittle: We’re reading about CVS and Humira biosimilars, Schumer’s broken insulin promise, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
Category: pharmalittle
.jpg)
STAT+: Pharmalittle: We’re reading about a J&J cough syrup, a Pfizer and Moderna patent suit, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: We’re reading about AstraZeneca CEO pay, alternatives to WuXi and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: We’re reading about drug shortages, Medicare spending on an Alzheimer’s drug, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, despite…
STAT+: Pharmalittle: We’re reading about a 486% drug price hike, AstraZeneca CEO pay, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
STAT+: Pharmalittle: We’re reading about biotech startups, Pfizer’s RSV vaccine, and more
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Pharmalittle: We’re reading about Biocon eyeing weight loss drugs, Sanofi layoffs, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: We’re reading about Boehringer biosimilar frustrations, FTC warnings, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: We’re reading about Amylyx pulling its ALS drug, GLP-1 drugs for Parkinson’s, and more
Top of the morning to you, and a fine one it is. After two days…
STAT+: Pharmalittle: We’re reading about a White House drug-shortage plan, a Genmab deal, and more
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: We’re reading about a European probe into vaccine talks; net drug prices falling, and more
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Pharmalittle: We’re reading about AstraZeneca’s CEO pay, an ALS drug spat in the U.K., and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: We’re reading about Wegovy insurance coverage, Zepbound shortages, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: We’re reading about a GLP-1 side effect, U.K. clinical trial transparency, and more
Top of the morning to you and a fine one it is. Despite cloudy skies…
STAT+: Pharmalittle: We’re reading about abortion pill arguments, a Merck drug approval, and more
Hello, everyone, and welcome to the middle of the week. Congratulations on making it this…
STAT+: Pharmalittle: We’re reading about Amgen suing Colorado over drug price caps, abortion pills, and more
Rise and shine, everyone, another busy day is on the way. How so? The evidence…
STAT+: Pharmalittle: We’re reading about a Novo Nordisk deal, a Regeneron setback, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, FDA syringe warnings, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: We’re reading about Medicare and obesity drugs, GSK asthma inhalers, and more
Top of the morning to you, and a fine one it is. Although quite chilly…
STAT+: Pharmalittle: We’re reading about Europe’s pharma reform, weight-loss meds, and more
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: Pharmalittle: We’re reading about an AstraZeneca deal, a WHO pandemic pact, and more
Rise and shine, everyone, another busy day is on the way. Already, the official mascots…
STAT+: Pharmalittle: We’re reading about CAR-T drugs for myeloma, CVS rebate credits, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: We’re reading about a liver-drug approval, pharma’s positive outlook, and more
And so, another working week will soon come to a close. Not a moment too…
STAT+: Pharmalittle: We’re reading about BIO cutting ties with WuXi, EU pharma rules, and more
Rise and shine, everyone, another busy day is on the way. We can tell because…
STAT+: Pharmalittle: We’re reading about Amazon delivering Zepbound, hemophilia treatments, and more
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: We’re reading about a failed schizophrenia drug trial, a Pfizer cancer drug, and more
Top of the morning to you, and a fine one it is. Sunny skies and…
STAT+: Pharmalittle: We’re reading about Wegovy approved for heart risks, an ALS drug puzzle, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: We’re reading about Lilly Alzheimer’s drug adcomm, Amylyx ALS drug flop, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: We’re reading about a Lilly obesity-drug ad, a $35 cap on inhalers, and more
Rise and shine, everyone, another busy day is on the way. Moreover, this is shaping…
STAT+: Pharmalittle: We’re reading about HIV drug resistance, march-in rights, and more
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Pharmalittle: We’re reading about Ozempic tackling kidney disease, OTC birth control, and more
Good morning, everyone, and how are you today? We are doing just fine, despite a…
STAT+: Pharmalittle: We’re reading about a nixed Medicare negotiation lawsuit, an Obamacare challenge, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: We’re reading about RSV vax link to GSB, a Pfizer donation, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: We’re reading about White House eyeing PBMs, Pfizer CEO’s frustrations, and more
Top of the morning to you, and a fine one it is. Cold winds and…
STAT+: Pharmalittle: We’re reading about Congress punts PBM reform, another obesity drug and more
Rise and shine, everyone, another busy day is on the way. Sadly, gray skies are…
STAT+: Pharmalittle: We’re reading about a pharma job slowdown, diet drugs boosting GDP, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: We’re reading about India-made versions of Wegovy, an RSV vaccine scramble, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Pharmalittle: We’re reading about a CEO change at AbbVie, a long-acting HIV drug, and more
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: Pharmalittle: We’re reading about weight loss drugs, a cell therapy for melanoma, and more
Good morning, everyone, and welcome to another working week, which is getting off to a…
.jpg)
STAT+: Pharmalittle: We’re reading about kids taking Wegovy, telehealth for abortion pills, and more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: We’re reading about a FTC probe into GPOs, a frostbite drug, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Pharmalittle: We’re reading about slow uptake of an Alzheimer’s drug, an opioid lawsuit, and more
Hello, everyone, and how are you today? We are doing just fine, thank you, especially…
STAT+: Pharmalittle: We’re reading about a tossed PhRMA lawsuit, secrecy clauses, and more
Rise and shine, everyone, another busy day is on the way. However, the pace this…
STAT+: Pharmalittle: We’re reading about Moderna’s RSV vaccine, Aurobindo problems, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: We’re reading about a U.S. vaccine panel, an abortion pill, and much more
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: We are reading about Catalent concerns, a congressional hearing, and more
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: We’re reading about worries over a Novo deal, a PBM bill, and more
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: Pharmalittle: We’re reading about a lawsuit against J&J, Express Scripts dealings, and more
Top of the morning to you, and a fine one it is. Clear blue skies…
STAT+: Pharmalittle: We’re reading about Novo buying Catalent, Amgen’s obesity drug, and more
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: We’re reading about opioid settlements, an OTC birth control pill, and more
And so, another working week will soon draw to a close. Not a moment too…